{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:13:29Z","timestamp":1764688409827},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[1997,11,1]],"date-time":"1997-11-01T00:00:00Z","timestamp":878342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[1997,11]]},"DOI":"10.1038\/nbt1197-1249","type":"journal-article","created":{"date-parts":[[2004,8,18]],"date-time":"2004-08-18T22:37:02Z","timestamp":1092868622000},"page":"1249-1252","source":"Crossref","is-referenced-by-count":47,"title":["Getting the right drug into the right patient"],"prefix":"10.1038","volume":"15","author":[{"given":"Andrew","family":"Marshall","sequence":"first","affiliation":[]}],"member":"297","reference":[{"key":"BFnbt11971249_CR1","unstructured":"Pharmaceutical Researchers and Manufacturers of America."},{"key":"BFnbt11971249_CR2","doi-asserted-by":"publisher","first-page":"12260","DOI":"10.1073\/pnas.92.26.12260","volume":"92","author":"J Poirer","year":"1995","unstructured":"Poirer,J. et al. 1995. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 92: 12260\u201312264.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt11971249_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1749-6632.1996.tb32603.x","volume":"802","author":"MR Farlow","year":"1996","unstructured":"Farlow, M.R. et al. 1996. Apolipoprotein E genotype and gender influence response to tacrine therapy. Ann. NY Acad. Sci. 802: 101\u2013110.","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnbt11971249_CR4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(97)80089-X","volume":"349","author":"F Richard","year":"1997","unstructured":"Richard, F. et al. 1997. APOE genotyping and response to drug treatment in Alzheimer's disease. Lancet 349: 539.","journal-title":"Lancet"},{"key":"BFnbt11971249_CR5","unstructured":"Department of Health and Human Services. 1997. Guidance for Industry: Drug Metabolism\/Drug Interaction Studies in the Drug Development Process: Studies in Vitro. FDA, Rockville, MD."}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nbt1197-1249","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt1197-1249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt1197-1249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:44:12Z","timestamp":1684439052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nbt1197-1249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":5,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["BFnbt11971249"],"URL":"https:\/\/doi.org\/10.1038\/nbt1197-1249","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,11]]}}}